TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||
Earning before tax | ---- | -32.51%-1.91B | ---- | 32.69%-1.44B | ---343.57M | -191.05%-2.14B | ---734.36M |
Profit adjustment | |||||||
Interest (income) - adjustment | ---- | -103.44%-102.69M | ---- | -259.15%-50.48M | ---5.32M | -143.50%-14.06M | ---5.77M |
Investment loss (gain) | ---- | 732.20%1.96M | ---- | -94.75%236K | --119K | 178.80%4.5M | --1.61M |
Impairment and provisions: | ---- | -75.17%217K | ---- | 29.87%874K | ---- | -89.53%673K | --6.43M |
-Other impairments and provisions | ---- | -75.17%217K | ---- | 29.87%874K | ---- | -89.53%673K | --6.43M |
Revaluation surplus: | ---- | 31.72%1.28B | ---- | -47.16%969.14M | --100.42M | 199.60%1.83B | --612.13M |
-Other fair value changes | ---- | 31.72%1.28B | ---- | -47.16%969.14M | --100.42M | 199.60%1.83B | --612.13M |
Asset sale loss (gain): | ---- | ---- | ---- | 87.93%-118K | ---129K | ---978K | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 87.93%-118K | ---129K | ---978K | ---- |
Depreciation and amortization: | ---- | 76.29%121.72M | ---- | 198.47%69.05M | --30.12M | 114.85%23.13M | --10.77M |
-Depreciation | ---- | 47.60%70.81M | ---- | 287.01%47.97M | --19.98M | 294.27%12.4M | --3.14M |
-Amortization of intangible assets | ---- | 53.21%5.68M | ---- | 243.15%3.71M | --1.54M | 3.35%1.08M | --1.05M |
Financial expense | ---- | 66.64%9.58M | ---- | 60.73%5.75M | --2.94M | 378.58%3.58M | --747K |
Exchange Loss (gain) | ---- | 782.93%40.37M | ---- | 37.29%-5.91M | ---6.31M | -1,250.43%-9.43M | ---698K |
Special items | ---- | -89.65%4.49M | ---- | 92.97%43.38M | --19.65M | 389.70%22.48M | --4.59M |
Operating profit before the change of operating capital | ---- | -36.24%-554.1M | ---- | -48.71%-406.7M | ---202.09M | -161.58%-273.48M | ---104.55M |
Change of operating capital | |||||||
Accounts receivable (increase)decrease | ---- | 89.96%-2.5M | ---- | 44.07%-24.94M | ---173K | -1.18%-44.59M | ---44.07M |
Accounts payable increase (decrease) | ---- | -68.90%8.33M | ---- | -43.75%26.79M | --1.8M | 364.83%47.62M | --10.25M |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---10.59M | ---- | ---28.91M |
Cash from business operations | ---- | -35.43%-548.27M | ---- | -49.70%-404.85M | ---211.04M | -61.67%-270.44M | ---167.28M |
Special items of business | -0.10%-299.29M | 20.46%-19.29M | ---298.99M | -245.28%-24.26M | ---- | --16.7M | ---- |
Net cash from operations | -0.10%-299.29M | -32.27%-567.56M | -41.67%-298.99M | -69.11%-429.1M | ---211.04M | -51.69%-253.75M | ---167.28M |
Cash flow from investment activities | |||||||
Interest received - investment | -35.08%42M | 346.94%102.12M | 970.11%64.69M | 36.14%22.85M | --6.05M | 486.44%16.78M | --2.86M |
Restricted cash (increase) decrease | -23.80%1.81M | -57.71%3.1M | -79.19%2.37M | 157.76%7.32M | --11.41M | ---12.67M | ---- |
Decrease in deposits (increase) | 26.26%830.52M | 161.50%1.3B | 156.84%657.77M | -1,373.80%-2.12B | ---1.16B | 144.28%166.34M | ---375.65M |
Sale of fixed assets | 634.15%301K | -94.37%84K | -92.60%41K | -61.53%1.49M | --554K | 387,700.00%3.88M | --1K |
Purchase of fixed assets | 24.98%-32.02M | 36.00%-123.79M | 52.07%-42.68M | -20.45%-193.42M | ---89.05M | -3,110.28%-160.58M | ---5M |
Selling intangible assets | --232K | ---- | ---- | --120K | --21K | ---- | --24K |
Purchase of intangible assets | 63.04%-2.17M | -28.79%-6.84M | -76.72%-5.86M | -71.42%-5.31M | ---3.32M | -100.13%-3.1M | ---1.55M |
Recovery of cash from investments | -62.99%675.08M | 20.22%2.3B | 627.91%1.82B | --1.91B | --250.57M | ---- | ---- |
Cash on investment | 15.35%-1.47B | -19.97%-2.87B | -132.53%-1.74B | -2,688.44%-2.4B | ---747.02M | -797.45%-85.91M | ---9.57M |
Other items in the investment business | -86.85%3.27M | 183.84%33.55M | 459.01%24.82M | 146.25%11.82M | --4.44M | -85.45%4.8M | --33M |
Net cash from investment operations | -93.83%48.65M | 126.67%735.58M | 145.72%788.03M | -3,813.64%-2.76B | ---1.72B | 80.20%-70.47M | ---355.88M |
Net cash before financing | -151.25%-250.64M | 105.27%168.02M | 125.28%489.04M | -882.96%-3.19B | ---1.93B | 38.03%-324.21M | ---523.16M |
Cash flow from financing activities | |||||||
New borrowing | --19.9M | 140.00%60M | ---- | 25.00%25M | ---- | -32.16%20M | --29.48M |
Refund | -650.00%-15M | -61.58%-36M | 68.15%-2M | -37.53%-22.28M | ---6.28M | ---16.2M | ---- |
Issuing shares | --901.08M | ---- | ---- | ---- | ---- | 38.52%2.48B | --1.79B |
Interest paid - financing | -16.24%-773K | 3.66%-1.55M | 19.69%-665K | 4.10%-1.61M | ---828K | -192.52%-1.68M | ---575K |
Absorb investment income | ---- | ---- | ---- | --68.21M | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---38.15M | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | --184.65M |
Net cash from financing operations | 4,220.91%828.06M | -144.64%-25.89M | -63.55%-20.09M | -97.66%57.99M | ---12.29M | 23.98%2.48B | --2B |
Effect of rate | 1,873.33%25.54M | -103.12%-5.59M | -100.95%-1.44M | 403.85%179.47M | --151.34M | 27.81%-59.07M | ---81.82M |
Net Cash | 23.13%577.41M | 104.54%142.13M | 124.09%468.95M | -245.41%-3.13B | ---1.95B | 45.98%2.15B | --1.47B |
Begining period cash | 23.78%710.76M | -83.70%574.22M | -83.70%574.22M | 146.25%3.52B | --3.52B | 3,596.02%1.43B | --38.72M |
Cash at the end | 26.11%1.31B | 23.78%710.76M | -39.71%1.04B | -83.70%574.22M | --1.73B | 146.25%3.52B | --1.43B |
Cash balance analysis | |||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.